Cognitive Dysfunction Clinical Trial
— SIMPLEOfficial title:
Shanghai Non-pharmacological Intervention of Mild Cognitive Impairment for Delaying Progress With Longitudinal Evaluation
| NCT number | NCT03119051 |
| Other study ID # | RuijinHSH |
| Secondary ID | |
| Status | Recruiting |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | May 15, 2017 |
| Est. completion date | May 2021 |
This study evaluates the effects of "computerized cognitive training" and "cognitive training plus exercise training" on different cognitive domains in mild cognitive impairment (MCI) patients. Patients will be randomized into the computerized training group, cognitive training plus exercise training group and the control group.
| Status | Recruiting |
| Enrollment | 250 |
| Est. completion date | May 2021 |
| Est. primary completion date | March 2021 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 50 Years to 85 Years |
| Eligibility |
Inclusion Criteria: - Male or female, aged 50-85; - MCI diagnosed according to the National Institute on Aging-Alzheimer's Association (NIA-AA) workgroups[1]; - 24=Mini-Mental State Examination (MMSE) =28; - The Hamilton Depression Scale/17-item (HAMD) score =10; - Not on medication for dementia; - MRI T2 weighted image (T2WI) scan: aged =70 , Fazeca scale for White Matter lesions rating level=1; >70 years, white matter damage rating scale =2. The number of lacunar infarcts larger than 2 cm in diameter =2. No infarcts in hypothalamus, entorhinal cortex, para-hypothalamus, cortical and subcortical cavity infarction near gray matter nuclei. The medial temporal lobe atrophy (MTA) score: Grade II or above. - Accompanied by reliable caregivers (at least intensive contact of 4 days every week and 2 hours every day) who are expected to participate in the follow-up visits and provide useful information for scores of scales like ADCS-ADL; - Education level: primary school (grade 6) or above. - Expected good compliance with the therapy and follow-up. Each patient gives a written informed consent, and the study has been approved by Ruijin Hospital's ethical committees. Exclusion Criteria: - Cognitive decline caused by other diseases (cerebrovascular disease, central nervous system infections, Parkinson's disease, metabolic encephalopathy, intracranial space-occupying lesions, deficiency of folic acid/vitamin B12 and hypothyroidism); - Medical history of other neurological disorders (including stroke, Neuromyelitis optica, Parkinson's disease, epilepsy, etc.); - Psychiatric disorders defined by (Diagnostic and Statistical Manual of Mental Disorders) DSM-IV criteria; - Unstable or severe disease of heart, lung, liver, kidney or hematopoietic system; - History of alcohol or drug abuse; - Participation in other clinical trial less than 30 days before the screening of this study; - Inability to complete the study. |
| Country | Name | City | State |
|---|---|---|---|
| China | Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine | Shanghai | Shanghai |
| Lead Sponsor | Collaborator |
|---|---|
| Ruijin Hospital | Huashan Hospital, RenJi Hospital, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
China,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Incidence of AD | The 3-year incidence of AD in each group will be compared. | 12 months | |
| Secondary | The global cognitive function of MCI patients | Alzheimer disease assessment scale (ADAS-Cog) will be used to assess the global cognitive performance of MCI patients | 6 months | |
| Secondary | Memory | Memory will be assessed using the Auditory verbal learning test-Huashan version (AVLT-H). | 12 months | |
| Secondary | Attention | Attention will be evaluated by Trial Making Test (TMT). | 12 months | |
| Secondary | Executive functions | Executive functions will be evaluated by the Stroop task. | 12 months | |
| Secondary | Language | Language will be assessed by Boston naming test (30-item version). | 12 months | |
| Secondary | Visual spatial ability and visual memory | Visual spatial ability and visual memory will be evaluated by the Rey-Osterrieth complex figure test (CFT). | 12 months | |
| Secondary | Activities of daily living | Activities of daily living will be assessed by Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL). | 6 months | |
| Secondary | Structural MRI | Volume of hippocampus and other specific brain regions | 12 months | |
| Secondary | Gut microbiota | Number of genera and abundence of E.coli in feces and blood | 12 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05273125 -
MOBility Disorders Assessment in Patients With Mild COGnitive Disorders
|
||
| Active, not recruiting |
NCT04049695 -
Improving Cognition After Cancer
|
N/A | |
| Completed |
NCT05912374 -
Adapting a Behavioral Intervention to Accommodate Cognitive Dysfunction in People Who Inject Drugs
|
N/A | |
| Recruiting |
NCT03977350 -
Association Between qEEG Measure and Post-Operative Cognitive Dysfunction (POCD) and Postoperative Delirium (POD)
|
||
| Not yet recruiting |
NCT06027632 -
Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer
|
N/A | |
| Terminated |
NCT00754052 -
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
|
Phase 3 | |
| Terminated |
NCT00754013 -
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
|
Phase 3 | |
| Completed |
NCT00719628 -
Depth of Anaesthesia and Cognitive Dysfunction
|
N/A | |
| Recruiting |
NCT05014399 -
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
|
||
| Completed |
NCT04966455 -
Effect of Raisins on Cognitive Function in Healthy Older Adults
|
Phase 3 | |
| Recruiting |
NCT05372159 -
Vanderbilt Memory and Aging Project
|
||
| Completed |
NCT03243279 -
BRS and Outcomes in Cardiothoracic Surgery
|
||
| Completed |
NCT04093882 -
The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease
|
||
| Recruiting |
NCT05732285 -
A Pilot Randomized Controlled Trial: CoINTEGRATE
|
N/A | |
| Completed |
NCT06059768 -
Urdu Translation and Psychometric Analysis of Lawton IADLS.
|
||
| Completed |
NCT04624529 -
Validity and Reliability of a Self-evaluation Tool for Cognitive Deficits in the Acute Stage After Stroke
|
||
| Completed |
NCT04562662 -
Evaluation of mediVR-KAGURA Guided Therapy
|
N/A | |
| Not yet recruiting |
NCT04079075 -
Multiple Interventions to Prevent Cognitive Decline
|
N/A | |
| Active, not recruiting |
NCT04638101 -
Building the Path to Resilience in Preterm Infants: Mindfulness-based Intervention
|
N/A | |
| Active, not recruiting |
NCT04556305 -
Lifestyle Physical Activity and Cognitive Training Interventions
|
N/A |